Obesity and Overweight is KILLING you University of California-Davis

The University of California-Davis is facing a growing problem of obesity and overweight among its students. One reason for this epidemic is the availability of unhealthy food options on campus. Many students choose to eat fast food and sugary snacks, which can contribute to weight gain. In fact, a study published in the Journal of American College Health found that 67% of college students do not meet the recommended daily intake of fruits and vegetables, leading to poor nutrition and weight gain.

Another reason for the obesity epidemic at UC Davis is a lack of physical activity among students. With busy schedules and academic pressures, many students struggle to find time to exercise. A study published in the Journal of Physical Activity and Health found that only 23% of college students meet the recommended guidelines for physical activity. This lack of exercise can lead to weight gain and other health problems. To combat this issue, the university could offer more healthy food options on campus and promote physical activity through programs and events. By addressing these factors, UC Davis can help students lead healthier lives and combat the obesity epidemic on campus.

Ready To Start

University of California-Davis weight loss REVOLUTION with Wegovy Ozempic, Zepbound and Mounjaro

At the University of California-Davis, scientists have made an amazing discovery in the world of weight loss with the introduction of semaglutide and tirzepatide, also known as GIP1 and GLP. These new medications work by mimicking the hormones in the body that help regulate blood sugar levels and control appetite. When taken as directed, they can help people lose weight by making them feel full and satisfied, leading to fewer calories consumed. The results of studies conducted at UC Davis have shown that patients who took these medications experienced significant weight loss, with some participants losing up to 10% of their body weight in just a few months. This revolutionary approach to weight loss has the potential to help millions of people struggling with obesity and related health issues. With the help of GIP1 and GLP, individuals can achieve their weight loss goals and improve their overall health and well-being.

Wegovy Ozempic, Zepbound, Mounjaro, Semaglutide, Tirzepatide, GLP1 and GIP: What is the difference?

Branded medications like Wegovy Ozempic, Zepbound, and Mounjaro can be very expensive. Sometimes insurance doesn’t want to pay for them, so it can be hard to get them covered. Even if insurance does cover them, the co-pays can still be really high. It can take many months to get all the approval forms in place before you can start taking them. On the other hand, generic medications like semaglutide and tirzepatide (GIP1/GLP) can be just as effective as the branded ones. They usually cost a lot less money, which can be a big relief. If you want to start losing weight right away, you can do that with the generic options available at University of California-Davis.
  • Increased energy levels
  • Improved cardiovascular health
  • Enhanced self-confidence
  • Better sleep quality
  • Reduced joint pain
  • Elevated mood stability
  • Lower blood pressure
  • Boosted immune system
  • Enhanced physical endurance
  • Improved mental clarity
  • Reduced diabetes risk
  • Greater mobility flexibility

The Game Changer

FDA-approved Wegovy®️, Ozempic®️, Mounjaro®️, Zepbound®️, Semaglutide, Tirzepatide, GLP1 and GIP weight loss medicine

It makes a BIG difference!

Watch the 60 Minutes CBS Report on FDA Approved Weight Loss Medicine

What Happens to My Body When I Loose Weight?

When you lose weight, your body undergoes numerous positive changes that can greatly improve your overall health and well-being. One of the most noticeable benefits is better sleep quality, as excess weight can lead to sleep apnea and other sleep disorders. By shedding pounds, you can experience deeper, more restful sleep, which can in turn boost your energy levels and mood during the day. In addition to improved sleep, losing weight can also reduce joint pain, lower blood pressure, and boost your immune system. These physical benefits can lead to enhanced physical endurance, better mental clarity, and reduced cholesterol levels. By shedding excess weight, you can also lower your risk of developing diabetes and improve your overall confidence. As a result, your clothes may fit better, your face may appear slimmer, and people may perceive you as smarter and more beautiful. Overall, the physical, mental, and emotional benefits of weight loss can greatly enhance your quality of life and help you feel your best.

Comparison of Weight Loss Medications Offered by LeadWest Medical

Medication Weight Loss Potential How It Works
Ozempic Up to 15% Regulates blood sugar and appetite
Wegovy Up to 20% Targets GLP-1 hormone for appetite suppression
Mounjaro Up to 27% Combines GLP-1 and GIP hormone action
Zepbound Varies Latest FDA-approved treatment for weight loss

Why Telemedicine is Safe and Better Solution for Weight Loss in University of California-Davis

Leadwest telemedicine service at University of California-Davis offers convenient health care options for students and staff. With online scheduling, individuals can easily book secure video online visits from their phone or laptop, eliminating the need to wait in a doctor’s office. This means no more commuting to the office, dealing with parking problems, or waiting in long lines. In addition to virtual appointments, Leadwest provides personalized SMS availability and coaching to support individuals on their health journey. Whether starting a weight loss program or managing a chronic condition, patients can receive the care they need from the comfort of their own home. Medication can even be shipped directly to their doorstep, making it easier than ever to stay on top of their health. Say goodbye to the hassle of traditional doctor visits and start your weight loss journey today with Leadwest telemedicine service at UC Davis.

Ozempic, Wegovy, Semaglutide, Zepbound, Mounjaro, Tirzepatide. What Are The RESULTS University of California-Davis

At the University of California-Davis, researchers have been studying the effectiveness of two popular weight loss medications: semaglutide and tirzepatide. According to recent studies, semaglutide has been shown to help patients lose an average of 15-20% of their body weight, while tirzepatide has been found to result in weight loss of around 10-15%. These statistics demonstrate the significant impact that these medications can have on helping individuals achieve their weight loss goals. When considering which medication may be more suitable for different patient profiles, it is important to note that semaglutide is typically recommended for individuals with a body mass index (BMI) of 27 or higher, while tirzepatide may be more appropriate for those with a BMI of 30 or higher. Additionally, both medications have been found to have minimal side effects, with nausea and diarrhea being the most commonly reported issues. Overall, the success of these weight loss medications at UC Davis has been impressive, with many patients experiencing significant weight loss and improvements in their overall health. One key difference between semaglutide and tirzepatide is their mechanism of action. Semaglutide works by mimicking the effects of a hormone called GLP-1, which helps to regulate appetite and blood sugar levels. On the other hand, tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it targets two different hormones involved in weight regulation. This dual action may provide some patients with added benefits in terms of weight loss and metabolic control. Ultimately, both medications have shown promise in helping individuals achieve their weight loss goals, and the experts at UC Davis are continuing to research and evaluate their effectiveness in different patient populations.
Schedule Now

Our Process

Pre-Qualify Questionaire
Insurance Process

Select your Brand Medication 
and determine insurance coverage

Up to 28 days to process,
supply or coverage may be limited

Pay Out-Of Pocket

Select your GLP-1 or GIP and determine
eligibility with Out-of-Pocket Cost 

Instant approval & no wait time
Access to all GLP-1 and GIP medications

Meet your medical provider
Start your comprehensive
GLP -1 program
REgister Now

Medication Options

With Insurance

Ozempic® & Wegovy®

15% average weight loss
Patient pays Co-Pay to Pharmacy**
Weight Loss Los Alamitos
Weight Loss Los Alamitos
With Insurance

Mounjaro® & Zepbound™

20% average weight loss
Patient pays Co-Pay to Pharmacy**
Weight Loss Los Alamitos
Weight Loss Los Alamitos
Without Insurance

Semaglutide (GLP-1)

Active ingredient in Ozempic® & Wegovy®
Semaglutide
Without Insurance

Tirzepatide (GLP-1 & GIP)

Active ingredient in Zepbound® & Mounjaro®
Tirzepatide

Why Are You Still Obese and Can Not Lose Weight in University of California-Davis

Patients at University of California-Davis can achieve better results by integrating diet and lifestyle changes with weight loss medications. Leadwest Medical clinic offers support by providing practical dietary tips, suggesting exercise routines, and connecting patients with local resources such as nutritionists or fitness centers. By combining medication with healthy eating habits and regular physical activity, patients can enhance the effectiveness of their weight loss journey. In addition to diet and exercise, behavior modification strategies are essential for maintaining long-term weight loss. Leadwest Medical clinic can help patients develop healthy habits and coping mechanisms to overcome challenges and temptations. By setting realistic goals, monitoring progress, and making sustainable lifestyle changes, patients can achieve lasting success in managing their weight. With the support and guidance of healthcare professionals, patients at University of California-Davis can take control of their health and achieve their weight loss goals.

Common obesity related diseases

Obesity is linked to several serious health conditions, including heart disease, type 2 diabetes, and certain cancers. These diseases can lead to decreased quality of life and increased mortality.

Obesity not only strains vital organs but also impairs mobility and energy levels, making daily activities more challenging. Effective weight management is crucial for reducing the risk of these health complications.

  • Heart disease
  • Type 2 diabetes
  • Stroke
  • High blood pressure
  • Sleep apnea
  • Fatty liver disease
  • Osteoarthritis
  • Gallbladder disease
  • Certain cancers
  • Kidney disease
  • Gastroesophageal reflux disease
  • Mental health disorders

University of California-Davis Residents Get Started Now Losing Weight with FDA Approved GLP1 and GIP Medicine

Are you a student at the University of California-Davis looking to receive personalized medical care without having to leave your home? Look no further than LeadWest Medical’s telemedicine services. Getting started is easy – simply fill out our pre-screening form online to provide us with some basic information about yourself. Once you’ve completed the form, you can schedule a telemedicine visit from the comfort of your own home. Our convenient same-day appointments make it easy to fit a visit into your busy schedule. During your telemedicine visit, you’ll have the opportunity to meet with one of our experienced doctors to discuss your personal medical history, any current conditions you may be experiencing, and the best medication options for your unique needs. Our doctors will provide personalized care and work with you to develop a treatment plan that is tailored to your specific health concerns. After your visit, prescriptions can be sent directly to your home or to your local pharmacy for easy pick-up. With LeadWest Medical, receiving quality medical care has never been more convenient.
Schedule Now
Testimonials

What Clients Are Saying

See For Yourself

Weight Loss FAQs

Semaglutide is a prescription medication used to treat type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of the naturally occurring hormone GLP-1 in the body. Tirzepatide mimics the GIP pathway in addition to the GLP-1 pathway.

These medications help regulate blood sugar levels. They also slow down the rate at which food moves through the stomach, which can reduce appetite and promote weight loss.

They are typically administered as a once-weekly injection. The appropriate dose will depend on the patient’s individual needs.

They are not a substitute for a healthy diet and exercise, and should be used in conjunction with these lifestyle changes to achieve optimal results. As with any medication, it is important to talk to your healthcare provider about the potential benefits and risks of these medications and whether they are the right choice for you.

These medications are used to treat type 2 diabetes and obesity.

Type 2 diabetes: They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. They may be used alone or in combination with other diabetes medications.

Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol.
Semaglutide is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis. It is also not recommended for use in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as semaglutide may increase the risk of these conditions.

As with any medication, they should only be prescribed by a healthcare provider who has evaluated the patient’s medical history, current health status, and individual needs and goals. Patients should follow their healthcare provider’s instructions for use and attend regular follow-up appointments to monitor progress and assess the need for continued treatment.

These medications can cause side effects in some patients. Some of the commonly reported side effects include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Loss of appetite
  • Headache
  • Fatigue
  • Dizziness

These side effects are usually mild to moderate in intensity and tend to improve over time as the body adjusts to the medication. However, if these side effects persist or become severe, patients should contact their healthcare provider for further evaluation and guidance.

In rare cases, they can cause more serious side effects such as:

  • Pancreatitis (inflammation of the pancreas)
  • Hypoglycemia (low blood sugar)
  • Kidney problems
  • Gallbladder problems
  • Allergic reactions

Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, persistent nausea or vomiting, rapid heartbeat, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Up to 20% with Semaglutide and up to 27% with Tirzepatid

Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity.

Patients who stop the medication gain back on average two thirds of the weight they had lost. It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight.

If your prior authorization is declined, your insurance will not cover the cost of the prescribed medication. In this instance, you have the option to self-fund your medication via our partnered pharmacies.

If you wish to share lab results, images, or any other relevant documents with your physician, you need to log into your Charm Tracker portal. Once there, select ‘Documents’ from the options and upload your documents.

The cost details of all our plans are clearly exhibited on our website. The flat-fee displayed for each plan is the total amount you’ll be required to pay each month or contact us today.

Schedule Now
Schedule Now
Skip to content